Search

everythinglearnresearchcommunity

for

Search:↓

Adalimumab significantly improves quality of life for patients with moderate to severe hidradenitis suppurativa.

Simvastatin/ezetimibe may help treat new cases of alopecia areata but not long-term cases.

A woman lost all her body hair after hepatitis C treatment, but it started to grow back a year after stopping the treatment.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Relapsing hepatitis A can cause prolonged abnormal liver tests even without symptoms.

We need safe, affordable drugs to fight coronaviruses effectively.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

Secukinumab and acitretin together may quickly and effectively treat severe generalized pustular psoriasis.

High-dose interferon is effective for chronic hepatitis C but often causes flu-like symptoms.

Azathioprine treatment led to rapid hair regrowth in a woman with alopecia universalis.

Promising cancer treatments were found, but the manufacturer closed.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Acitretin treats severe skin conditions but requires careful monitoring due to serious side effects.

Six African American women experienced hair loss after switching to a new HIV medication.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Isotretinoin effectively treated severe acne in HIV-positive women, with improved skin and CD4 counts, but some experienced side effects like skin dryness and hair loss.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

Upadacitinib may effectively treat resistant lichen planopilaris.

A woman with HIV had a severe skin condition that improved with antiretroviral therapy.

Hair antiretroviral concentration is affected by hair type, segment position, housing, drug use, sexual behavior, kidney function, and genetics.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Upadacitinib effectively treats severe alopecia areata and is safe.